PEC vs A Plus Biotech: monthly revenue

Monthly revenue and year-on-year change for PEC (6446) and A Plus Biotech (6918) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ PEC ━ A Plus Biotech

0%+108%-7%25/1026/0126/0426/0726/10

Monthly revenue history

MonthPECYoYA Plus BiotechYoY
Oct 2026NT$2.84 billion+102.0%NT$81.1 million+29.8%
Sep 2026NT$2.64 billion+100.0%NT$79.5 million+13.4%
Aug 2026NT$2.62 billion+105.4%NT$76.6 million+11.0%
Jul 2026NT$2.51 billion+92.6%NT$86 million+20.1%
Jun 2026NT$2.33 billion+94.9%NT$79.2 million+4.2%
May 2026NT$2.46 billion+108.5%NT$78.9 million+27.2%
Apr 2026NT$2.06 billion+68.3%NT$84.9 million+11.9%
Mar 2026NT$1.94 billion+64.4%NT$73.8 million+16.2%
Feb 2026NT$1.6 billion+56.7%NT$74.2 million+6.5%
Jan 2026NT$1.58 billion+49.8%NT$71.4 million+13.0%
Dec 2025NT$1.92 billion+69.9%NT$72 million-1.5%
Nov 2025NT$1.55 billion+53.0%NT$80.4 million+25.1%
Oct 2025NT$1.4 billion+53.6%NT$62.5 million-7.0%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16